Cite
HARVARD Citation
Tisi, M. et al. (n.d.). Rituximab, bendamustine and cytarabine (R‐BAC) in patients with relapsed‐refractory aggressive B‐ and T‐cell lymphoma. Hematological oncology. pp. 345-346. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tisi, M. et al. (n.d.). Rituximab, bendamustine and cytarabine (R‐BAC) in patients with relapsed‐refractory aggressive B‐ and T‐cell lymphoma. Hematological oncology. pp. 345-346. [Online].